RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Mootoo to Galactosylceramides

This is a "connection" page, showing publications David Mootoo has written about Galactosylceramides.
Connection Strength

2.842
  1. Altiti AS, Ma X, Zhang L, Ban Y, Franck RW, Mootoo DR. Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues. Carbohydr Res. 2017 Apr 18; 443-444:73-77.
    View in: PubMed
    Score: 0.606
  2. Altiti AS, Bachan S, Mootoo DR. The Crotylation Way to Glycosphingolipids: Synthesis of Analogues of KRN7000. Org Lett. 2016 09 16; 18(18):4654-7.
    View in: PubMed
    Score: 0.584
  3. Altiti AS, Mootoo DR. C-glycosphingolipid precursors via iodocyclization of homoallyic trichloroacetimidates. Carbohydr Res. 2015 Apr 30; 407:148-53.
    View in: PubMed
    Score: 0.526
  4. Altiti AS, Mootoo DR. Intramolecular nitrogen delivery for the synthesis of C-glycosphingolipids. Application to the C-glycoside of the immunostimulant KRN7000. Org Lett. 2014 Mar 07; 16(5):1466-9.
    View in: PubMed
    Score: 0.491
  5. Augustin LA, Fantini J, Mootoo DR. C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120. Bioorg Med Chem. 2006 Feb 15; 14(4):1182-8.
    View in: PubMed
    Score: 0.275
  6. Ban Y, Dong W, Zhang L, Zhou T, Altiti AS, Ali K, Mootoo DR, Blaho VA, Hla T, Ren Y, Ma X. Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis. Front Immunol. 2019; 10:404.
    View in: PubMed
    Score: 0.174
  7. Bachan S, Fantini J, Joshi A, Garg H, Mootoo DR. Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides. Bioorg Med Chem. 2011 Aug 15; 19(16):4803-11.
    View in: PubMed
    Score: 0.102
  8. Garg H, Francella N, Tony KA, Augustine LA, Barchi JJ, Fantini J, Puri A, Mootoo DR, Blumenthal R. Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry. Antiviral Res. 2008 Oct; 80(1):54-61.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support